Healthcare Regulation (HIPAA)

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

A Minnesota jury found major companies liable for a man's terminal cancer from asbestos in talc powders, highlighting a growing legal battle.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.

With a new CEO who led a startup to FDA approval and acquisition, VahatiCor aims to commercialize its novel A-FLUX system for millions with chronic chest pain.

A new $17.9M government contract will fund an AI to analyze phone data, aiming to revolutionize how we detect and treat behavioral health issues.

Beyond just tracking data, SIBIONICS's new AI tools aim to tell diabetes patients what to do next, heralding a new era of personalized care.

A new tool from a national lab uses de-identified test data to give health officials an early warning on emerging disease threats like pertussis and flu.

ODAIA's new AI platform moves beyond static segments to treat each doctor as a 'segment of one,' promising to boost engagement and slash marketing waste.

Former Trade Desk CMO Ian Colley joins DeepIntent, signaling an aggressive push into AI-powered marketing for the specialized healthcare advertising sector.

A new partnership aims to tackle AI's biggest security risks, signaling a major industry shift from functional AI to production-ready, secure AI.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

A new survey reveals a massive gap between security goals and reality, as nearly all firms want microsegmentation but few successfully deploy it.

H1 launched its Site Network Suite, an AI platform promising to slash clinical trial feasibility times and reshape how sponsors and research sites connect.

Cirrascale and Google Cloud are bringing Gemini to private data centers, ending the security vs. innovation tradeoff for regulated industries.

As breach costs hit $10.9M and new laws tighten, Nexcess launches a managed hosting solution designed to secure patient data and ensure HIPAA compliance.

As AI projects falter on bad data, companies learn that automation without human oversight is a risky bet, especially in regulated industries.

A new AI platform is revolutionizing how pharma creates complex scientific videos, earning industry award recognition for its speed, savings, and compliance.

C-mo Medical Solutions has received European approval for its AI-powered wearable, a device poised to transform respiratory care with objective, private data.

A proposed $108.5M FDA funding boost aims to modernize infant formula rules, paving the way for plant-based options and a more secure supply chain.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.